Literature DB >> 26783096

Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study).

Samantha Fraser-Bell1, Lyndell L Lim2, Anna Campain1, Hemal Mehta3, Christine Aroney1, Jaclyn Bryant1, Ji Li1, Godfrey J Quin4, Ian L McAllister5, Mark C Gillies1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26783096     DOI： 10.1016/j.ophtha.2015.12.012

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  18 in total

1.  Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response.

Authors:  Gokhan Demir; Abdullah Ozkaya; Elmas Yuksel; Gurkan Erdogan; Ugur Tunc; Mevlut Celal Ocal; Yasin Sakır Goker
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

Review 2.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 3.  Emerging Insights and Interventions for Diabetic Retinopathy.

Authors:  Avinash Honasoge; Eric Nudleman; Morton Smith; Rithwick Rajagopal
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

4.  Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.

Authors:  Thibaud Mathis; Théo Lereuil; Amro Abukashabah; Nicolas Voirin; Aditya Sudhalkar; Alper Bilgic; Philippe Denis; Corinne Dot; Laurent Kodjikian
Journal:  Acta Diabetol       Date:  2020-07-12       Impact factor: 4.280

Review 5.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

Review 6.  Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.

Authors:  Hemal Mehta; Charles Hennings; Mark C Gillies; Vuong Nguyen; Anna Campain; Samantha Fraser-Bell
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

7.  Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.

Authors:  Ahmed Hosni Abd Elhamid
Journal:  Open Ophthalmol J       Date:  2017-07-21

8.  Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.

Authors:  A Meireles; C Goldsmith; I El-Ghrably; A Erginay; M Habib; B Pessoa; J Coelho; T Patel; R Tadayoni; P Massin; J Atorf; A J Augustin
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 9.  Dexamethasone implant in the management of diabetic macular edema from clinician's perspective.

Authors:  Mojca Urbančič; Ivana Gardašević Topčić
Journal:  Clin Ophthalmol       Date:  2019-05-13

10.  Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.

Authors:  HyunJeong Cho; Kyung Seek Choi; Joo Yong Lee; Donghwan Lee; Nam-Kyong Choi; YouKyung Lee; SeungJin Bae
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.